Medifast Inc. (MED)
NYSE
Closed
Oct 8, 2026
Day's Range
11.3852 wk Range
9.22Overview - MED - Medifast Inc.
Key Statistics
Valuation
Enterprise Value
-20.93M
P/E (Trailing)
‪531.50‬
P/E (Forward)
‪-41.89‬
PEG Ratio
‪-2.39‬
Price / Sales (TTM)
‪0.41‬
Price / Book
‪0.61‬
EV / EBITDA
‪3.69‬
Profitability
Gross Margin
‪69.90%‬
Profit Margin
‪-8.07%‬
Operating Margin
‪-5.66%‬
Return on Assets
‪-4.60%‬
Return on Equity
‪-12.41%‬
Ownership
Shares Outstanding
11.18M
Float
8.45M
Short % of Shares Outstanding
‪17.25%‬
Held by Insiders
‪4.33%‬
Held by Institutions
‪75.33%‬
Price stats
Beta
‪0.73‬
50-Day Avg
‪11.68‬
200-Day Avg
‪11.25‬
Dividends
Payout Ratio
‪0.00%‬
Frequency
Quarterly
Analyst Consensus
1 analysts
Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - MED - Medifast Inc.
Peers - MED - Medifast Inc.
Peer Comparison
Compared with companies in Engineering & Construction listed on NYSE.
Profile Summary - MED - Medifast Inc.
About
Medifast Inc. is a health and wellness company focused on habit-based, coach-guided lifestyle solutions for weight management and metabolic health. The company’s core offering centers on the OPTAVIA brand, which combines structured nutrition products, meal replacements, and coaching support to help customers build…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
